Sorrento Ch. 11 Will Stay In Texas

By Rick Archer · March 12, 2024, 7:35 PM EDT

A Texas bankruptcy judge Tuesday denied requests to transfer the Chapter 11 case of drug developer Sorrento Therapeutics Inc. out of the Lone Star State for having insufficient ties to the...

To view the full article, register now.

Bankruptcy Scorecard

Summary

California biopharmaceutical firm Sorrento Therapeutics Inc., filed for Chapter 11 protection with about $135 million in debt, in the face of a $175 million arbitration award.

Case Number

4:23-bk-90085

Judge

Christopher M. Lopez

Venue

U.S. Bankruptcy Court for the Southern District of Texas

Capital Structure

View Full Scorecard

Documents

Case Information

Case Title

Sorrento Therapeutics, Inc.

Case Number

4:23-bk-90085

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023